Security
MEDIROM Healthcare Technologies Inc. American Depositary Share · MRM
MRMNASDAQotherCurrentCIK 1819704Updated Oct 14, 2026
MRM price & chart
Loading TradingView…
NASDAQ:MRM on TradingView ↗In the news
No coverage from other publishers is available.
Seeking Alpha
Financials
FY 2024 · JPYSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsJPY | 8,090,671,000Source | 6,849,189,000Source | 6,747,346,000Source | 5,753,061,000Source |
| Property, Plant and Equipment, NetJPY | 435,659,000Source | 451,498,000Source | 424,288,000Source | 424,996,000Source |
| GoodwillJPY | 389,131,000Source | 484,564,000Source | 539,490,000Source | 600,329,000Source |
| Intangible Assets, Net (Excluding Goodwill)JPY | 1,139,297,000Source | 920,700,000Source | 403,674,000Source | 391,038,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,093,000Source | 755,000Source | 4,593,000Source | 370,617,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentJPY | 1,355,489,000Source | 621,867,000Source | 534,686,000Source | 312,302,000Source |
| Inventory, NetJPY | 151,637,000Source | 139,982,000Source | 114,109,000Source | 18,703,000Source |
| Assets, CurrentJPY | 2,706,062,000Source | 1,758,704,000Source | 2,363,211,000Source | 1,382,302,000Source |
| Prepaid Expense and Other Assets, CurrentJPY | 217,174,000Source | 257,932,000Source | 292,643,000Source | 111,166,000Source |
| Operating Lease, Right-of-Use AssetJPY | 2,073,763,000Source | 2,089,402,000Source | 1,955,354,000Source | 1,824,095,000Source |
| Other Assets, NoncurrentJPY | 80,571,000Source | 16,655,000Source | 13,666,000Source | 107,224,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesJPY | 6,902,613,000Source | 6,633,228,000Source | 6,806,724,000Source | 5,961,404,000Source |
| Stockholders’ equity: | ||||
| Retained Earnings (Accumulated Deficit)JPY | 229,040,000Source | 80,277,000Source | -2,545,068,000Source | -2,694,033,000Source |
| Stockholders' Equity Attributable to ParentJPY | 933,268,000Source | 210,879,000Source | -59,378,000Source | -208,343,000Source |
| Additional Paid in Capital, Common StockJPY | 354,605,000Source | 113,602,000Source | 1,265,456,000Source | 1,265,456,000Source |
| Liabilities and EquityJPY | 8,090,671,000Source | 6,849,189,000Source | 6,747,346,000Source | 5,753,061,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentJPY | 4,181,481,000Source | 3,560,593,000Source | 3,641,967,000Source | 3,196,473,000Source |
| Operating Lease, Liability, CurrentJPY | 792,781,000Source | 763,422,000Source | 769,769,000Source | 755,219,000Source |
| Accounts Payable, CurrentJPY | 1,014,205,000Source | 137,697,000Source | 207,581,000Source | 230,899,000Source |
| Operating Lease, Liability, NoncurrentJPY | 1,287,509,000Source | 1,334,630,000Source | 1,212,629,000Source | 1,128,737,000Source |
| Other Liabilities, NoncurrentJPY | 17,424,000Source | 9,801,000Source | 30,422,000Source | 25,176,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestJPY | 54,630,000Source | 5,082,000Source | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentJPY | 325,544,000Source | 1,261,909,000Source | 1,383,579,000Source | 865,865,000Source |
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Current MaturitiesJPY | 620,813,000Source | 100,415,000Source | 99,168,000Source | 162,252,000Source |
| Long-term Debt, Excluding Current MaturitiesJPY | 764,200,000Source | 1,050,802,000Source | 1,149,769,000Source | 746,588,000Source |
| Redeemable Noncontrolling Interest, Equity, Carrying AmountJPY | 200,160,000Source | — | 0Source | 148,000,000Source |
| Short-term InvestmentsJPY | 6,156,000Source | 26,502,000Source | 26,500,000Source | 26,526,000Source |
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestJPY | 138,191,000Source | 115,049,000Source | 148,965,000Source | -990,731,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationJPY | 290,038,000Source | 252,595,000Source | 184,056,000Source | 126,243,000Source |
| Share-based Payment Arrangement, Noncash ExpenseJPY | — | — | — | 196,853,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableJPY | -339,120,000Source | -580,681,000Source | 222,384,000Source | 37,024,000Source |
| Increase (Decrease) in InventoriesJPY | 10,612,000Source | 25,873,000Source | 95,406,000Source | 2,441,000Source |
| Increase (Decrease) in Accounts PayableJPY | 876,508,000Source | -69,884,000Source | -23,318,000Source | 58,437,000Source |
| Deferred Income Tax Expense (Benefit)JPY | -188,706,000Source | -101,636,000Source | — | 551,483,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesJPY | -1,331,681,000Source | -631,737,000Source | -685,697,000Source | -557,231,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredJPY | 21,348,000Source | — | 148,000,000Source | 375,757,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesJPY | 361,393,000Source | -328,576,000Source | 580,437,000Source | -83,936,000Source |
| Payments to Acquire Property, Plant, and EquipmentJPY | 71,408,000Source | 135,840,000Source | 120,740,000Source | 95,651,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesJPY | 1,193,340,000Source | 461,206,000Source | 340,097,000Source | -427,949,000Source |
| Repayments of Long-term DebtJPY | 96,708,000Source | 99,084,000Source | 45,270,000Source | 251,084,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectJPY | 223,052,000Source | -499,107,000Source | 234,837,000Source | -1,069,116,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesJPY | 47,558,000Source | 34,575,000Source | 7,535,000Source | 10,865,000Source |
| Income Taxes Paid, NetJPY | 12,777,000Source | 52,105,000Source | 30,809,000Source | 45,505,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsJPY | 182,413,000Source | 145,555,000Source | 85,918,000Source | 45,780,000Source |
| Asset Retirement Obligation, Accretion ExpenseJPY | 3,781,000Source | 3,095,000Source | 24,424,000Source | 2,172,000Source |
| DepreciationJPY | 100,462,000Source | 107,040,000Source | 82,795,000Source | 80,463,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxJPY | 18,121,000Source | 26,825,000Source | 14,830,000Source | 14,992,000Source |
| Gain (Loss) on Disposition of AssetsJPY | 40,631,000Source | 413,678,000Source | — | — |
| Gain (Loss) on Disposition of BusinessJPY | — | — | — | -2,692,000Source |
| GoodwillJPY | 389,131,000Source | 484,564,000Source | 539,490,000Source | 600,329,000Source |
| Goodwill, Impairment LossJPY | 0Source | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)JPY | — | 0Source | 0Source | — |
| Income Tax Expense (Benefit)JPY | -90,478,000Source | -94,427,000Source | 30,809,000Source | 576,250,000Source |
| InterestExpenseNonoperatingJPY | 49,745,000Source | — | — | — |
| Investment Income, InterestJPY | 8,000Source | 1,111,000Source | 6,072,000Source | 839,000Source |
| Net Income (Loss) Attributable to ParentJPY | 148,763,000Source | 115,404,000Source | 148,965,000Source | -990,731,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestJPY | — | -355,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicJPY | — | — | 148,965,000Source | -990,731,000Source |
| Nonoperating Income (Expense)JPY | 65,815,000Source | 412,201,000Source | 82,807,000Source | 56,106,000Source |
| Operating Lease, ExpenseJPY | 89,120,000Source | — | — | — |
| Operating Lease, Impairment LossJPY | — | — | — | 20,979,000Source |
| Other Nonoperating Income (Expense)JPY | 42,943,000Source | -13,923,000Source | 51,078,000Source | 24,377,000Source |
| Proceeds from Issuance of Long-term DebtJPY | 300,000,000Source | — | 547,619,000Source | — |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Total RevenueJPY | 8,299,134,000Source | 6,827,943,000Source | 6,954,057,000Source | 5,409,825,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseJPY | 2,241,515,000Source | 1,960,447,000Source | 1,805,490,000Source | 1,822,787,000Source |
| Operating Income (Loss)JPY | -18,102,000Source | -391,579,000Source | 96,967,000Source | -470,587,000Source |
| Other Nonoperating Income (Expense)JPY | 42,943,000Source | -13,923,000Source | 51,078,000Source | 24,377,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestJPY | 47,713,000Source | 20,622,000Source | 179,774,000Source | -414,481,000Source |
| Income Tax Expense (Benefit)JPY | -90,478,000Source | -94,427,000Source | 30,809,000Source | 576,250,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestJPY | — | -355,000Source | — | — |
| Net Income (Loss) Attributable to ParentJPY | 148,763,000Source | 115,404,000Source | 148,965,000Source | -990,731,000Source |
| Earnings Per Share, BasicJPY/shares | 29.13Source | 23.64Source | 30.54Source | -203.13Source |
| Earnings Per Share, DilutedJPY/shares | 28.52Source | 22.34Source | 27.23Source | -203.13Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 5,107,405Source | 4,882,501Source | 4,877,404Source | 4,877,404Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 5,851,516Source | 5,166,653Source | 5,470,654Source | 4,877,404Source |
| Interest Expense (non-operating)JPY | 49,745,000Source | — | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsJPY | 182,413,000Source | 145,555,000Source | 85,918,000Source | 45,780,000Source |
| Costs and ExpensesJPY | 8,317,236,000Source | 7,219,522,000Source | 6,857,090,000Source | 5,880,412,000Source |
| Current Income Tax Expense (Benefit)JPY | 98,228,000Source | 7,209,000Source | 30,809,000Source | 24,767,000Source |
| Depreciation, Depletion and Amortization, NonproductionJPY | 176,413,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxJPY | 18,121,000Source | 26,825,000Source | 14,830,000Source | 14,992,000Source |
| Goodwill, Impairment LossJPY | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitJPY | 2,246,285,000Source | — | — | — |
| Interest ExpenseJPY | — | 36,868,000Source | 9,800,000Source | 11,950,000Source |
| Investment Income, InterestJPY | 8,000Source | 1,111,000Source | 6,072,000Source | 839,000Source |
| Labor and Related ExpenseJPY | 718,456,000Source | — | — | — |
| Net Income (Loss) Attributable to Nonredeemable Noncontrolling InterestJPY | -10,572,000Source | — | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicJPY | — | — | 148,965,000Source | -990,731,000Source |
| Nonoperating Income (Expense)JPY | 65,815,000Source | 412,201,000Source | 82,807,000Source | 56,106,000Source |
| Operating Lease, ExpenseJPY | 89,120,000Source | — | — | — |
| Selling ExpenseJPY | 181,159,000Source | — | — | — |
Filing attachments
mrm-ex99_1.htm · 6-K · 2026-10-13
Exhibit 99.1 MEDIROM Healthcare Technologies Inc. Receives Notification from Nasdaq Related to Closing Bid Price Tokyo, Japan - October 13, 2026 - MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Kouji Eguchi; listed on the Nasdaq Capital Market: NASDAQ: MRM) (the “Company”) announced today that on October 6, 2026, the Company received a written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company t…
Read attachment ↗mrm-ex99_1.htm · 6-K · 2026-08-27
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) Exhibit 99.1 MEDIROM Group Reports Q2 2026 Results TOKYO, August 27, 2026 Company: MEDIROM Healthcare Technologies Inc. Headquarters: 2-3-1 Daiba, Minato-ku, Tokyo This report presents an overview of our business performance and key performance indicators (KPIs) for the second quarter of 2026 (April - June 2026). It also highlights trends over the past five quarters (2025Q2 - 2026Q2) to provide investors with a broader perspective. Data inc…
Read attachment ↗mrm-ex99_1.htm · 6-K · 2026-08-27
Press Release Exhibit 99.1 MEDIROM “Surpasses 50,000 Cumulative World ID Human Verifications Across Its Stores” Completing the Initial Rollout Phase for World, Moving to Storefront Installation for Stable Access Tokyo, Japan - August 27, 2026 - MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM, “MEDIROM” or the “Company”) is pleased to announce that the cumulative number of human verifications conducted through World ID’s Orb has surpassed 50…
Read attachment ↗mrm-ex99_1.htm · 6-K · 2026-06-25
Exhibit 99.1 MEDIROM MOTHER Labs Expands Deployment of "REMONY®" Remote Health Monitoring System in JGSDF 8th Division - Additional Orders Triple Implementation Scale; "MOTHER Bracelet®" Enables Continuous Safety Monitoring During Extended Training MEDIROM MOTHER Labs Expands Deployment of "REMONY" Remote Health Monitoring System in JGSDF 8th Division Remote Health Monitoring System Tokyo, Japan - June 25, 2026 - MEDIROM MOTHER Labs Inc. (Headquarters: Minato-ku, Tokyo; President: Yoshio Ueku…
Read attachment ↗mrm-ex99_1.htm · 6-K · 2026-05-29
Exhibit 99.1 MEDIROM Healthcare Technologies Inc. Receives Notification from Nasdaq Related to Annual Report Tokyo, Japan - May 29, 2026 - MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Kouji Eguchi; listed on the Nasdaq Capital Market: NASDAQ: MRM) (the “Company”) announced today that on May 26, 2026, the Company received a notice from the Listings Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company…
Read attachment ↗mrm-ex99_1.htm · 6-K · 2026-05-28
MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) Exhibit 99.1 MEDIROM Group Reports Q1 2026 Results TOKYO, May 28, 2026 Company: MEDIROM Healthcare Technologies Inc. Headquarters: 2-3-1 Daiba, Minato-ku, Tokyo This report presents an overview of our business performance and key performance indicators (KPIs) for the first quarter of 2026 (January - March 2026). It also highlights trends over the past five quarters (2025Q1 - 2026Q1) to provide investors with a broader perspective. Data incl…
Read attachment ↗